Alpha Pro Tech Ltd
APT NYSE Orthopedic, Prosthetic & Surgical Appliances & Supplies Financials FY2016βFY2025
Last close Β· Oct 23, 2026
$5.56
0.5%What Alpha Pro Tech Ltd does
No business description yet.
- Legal name
- ALPHA PRO TECH LTD
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 11, 2026
- Accession Β· CIK
- 0001437749-26-007797
0000884269
Revenue and margins
Alpha Pro Tech Ltd had $59.1M of revenue in fiscal 2025, up 2.3% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 6.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.7M in fiscal 2025, 2.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Alpha Pro Tech Ltd returned $3.3M to shareholders in fiscal 2025, 193% of free cash flow. The diluted share count fell 6.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Alpha Pro Tech Ltd can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $16.3M | $16.3M | $20.4M | $18.6M | $17.0M |
| Current ratio | 19.9x | 21.8x | 20.7x | 16.2x | 12.9x |
| Quick ratio | 10.5x | 11.7x | 12.8x | 8.9x | 7.1x |
| Total assets | $67.0M | $64.8M | $68.8M | $73.7M | $74.1M |
| Total liabilities | $5.3M | $4.0M | $7.2M | $11.5M | $11.7M |
| Shareholders' equity | $61.8M | $60.8M | $61.6M | $62.2M | $62.5M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 6 / 8 | 6 / 8 | 4 / 8 | 5 / 8 | 3 / 8 | 5 / 8 | 6 / 8 | 5 / 8 | 4 / 8 |
| Accruals ratio | β10.2% | β3.9% | 4.8% | β0.3% | 16.1% | 10.7% | β1.5% | β6.4% | β2.5% | 1.6% |
| Altman Z'' | 18.20 | 19.47 | 24.66 | 14.51 | 17.36 | 21.07 | 23.60 | 16.41 | 12.31 | 12.40 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $46.2M | $44.0M | $46.6M | $46.7M | $103M | $68.6M | $62.0M | $61.2M | $57.8M | $59.1M |
| Gross profit | $17.0M | $17.5M | $17.7M | $17.0M | $50.5M | $25.3M | $21.7M | $22.8M | $22.9M | $22.5M |
| Research and development | $0.0M | $0.0M | β | β | β | β | β | β | β | β |
| Operating income | $3.7M | $2.9M | $3.9M | $3.0M | $31.6M | $7.9M | $4.7M | $4.1M | $3.4M | $3.8M |
| Income tax | $1.0M | $1.0M | $0.8M | $0.7M | $5.4M | $1.7M | $1.1M | $1.2M | $1.1M | $1.1M |
| Net income | $3.2M | $2.6M | $3.6M | $3.0M | $26.9M | $6.8M | $3.3M | $4.2M | $3.9M | $3.5M |
| Diluted EPS | $0.19 | $0.18 | $0.26 | $0.23 | $1.92 | $0.50 | $0.26 | $0.35 | $0.35 | $0.33 |
| Diluted shares | 0.02B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $6.8M | $4.0M | $2.0M | $3.1M | $18.3M | β$0.5M | $4.3M | $8.5M | $5.7M | $2.4M |
| Capital expenditure | $0.3M | $1.2M | $0.6M | $1.3M | $1.1M | $2.5M | $0.5M | $0.8M | $3.8M | $0.6M |
| Free cash flow | $6.6M | $2.8M | $1.4M | $1.8M | $17.1M | β$3.0M | $3.8M | $7.7M | $1.9M | $1.7M |
| Depreciation and amortization | $0.5M | $0.6M | $0.5M | $0.6M | $0.7M | $0.8M | $0.8M | $0.9M | $0.9M | $0.9M |
| Stock-based compensation | $0.2M | $0.3M | $0.4M | $0.5M | $0.4M | $0.3M | $0.1M | $0.2M | $0.5M | $0.5M |
| Share buybacks | $6.8M | $4.2M | $3.6M | $2.5M | $2.7M | $4.4M | $3.9M | $4.0M | $4.5M | $3.3M |
| Dividends and buybacks | $6.8M | $4.2M | $3.6M | $2.5M | $2.7M | $4.4M | $3.9M | $4.0M | $4.5M | $3.3M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $9.5M | $8.8M | $7.0M | $6.5M | $23.3M | $16.3M | $16.3M | $20.4M | $18.6M | $17.0M |
| Finance lease liabilities | β | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $29.7M | $27.0M | $26.5M | $26.1M | $55.2M | $53.0M | $52.6M | $53.1M | $50.6M | $52.5M |
| Current liabilities | $2.5M | $2.8M | $1.9M | $2.3M | $5.9M | $2.7M | $2.4M | $2.6M | $3.1M | $4.1M |
| Inventory | $11.0M | $10.2M | $9.9M | $11.3M | $16.7M | $25.0M | $24.4M | $20.1M | $22.7M | $23.6M |
| Property and equipment, net | $2.6M | $3.2M | $3.2M | $3.9M | $4.4M | $6.1M | $5.7M | $5.6M | $8.5M | $8.2M |
| Goodwill | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M |
| Intangible assets | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | β | β |
| Total assets | $35.9M | $34.1M | $34.3M | $38.1M | $68.7M | $67.0M | $64.8M | $68.8M | $73.7M | $74.1M |
| Total liabilities | $3.3M | $2.8M | $2.1M | $4.9M | $9.1M | $5.3M | $4.0M | $7.2M | $11.5M | $11.7M |
| Shareholders' equity | $32.7M | $31.3M | $32.2M | $32.9M | $58.8M | $61.8M | $60.8M | $61.6M | $62.2M | $62.5M |
| Margins | ||||||||||
| Gross margin | 36.8% | 39.6% | 38.0% | 36.4% | 49.2% | 36.9% | 35.0% | 37.3% | 39.6% | 38.1% |
| Operating margin | 8.0% | 6.6% | 8.3% | 6.5% | 30.8% | 11.5% | 7.5% | 6.7% | 6.0% | 6.5% |
| EBITDA margin | 9.1% | 7.9% | 9.4% | 7.8% | 31.5% | 12.7% | 8.8% | 8.3% | 7.5% | 8.1% |
| Net margin | 6.9% | 6.0% | 7.8% | 6.4% | 26.2% | 9.8% | 5.3% | 6.8% | 6.8% | 6.0% |
| FCF margin | 14.2% | 6.3% | 3.0% | 3.9% | 16.7% | β4.4% | 6.1% | 12.5% | 3.3% | 2.9% |
| Returns | ||||||||||
| Return on capital employed | 11.0% | 9.3% | 12.0% | 8.4% | 50.3% | 12.3% | 7.5% | 6.2% | 4.9% | 5.5% |
| Return on equity | 9.7% | 8.2% | 11.4% | 9.2% | 58.6% | 11.2% | 5.4% | 6.8% | 6.3% | 5.7% |
| Return on assets | 8.8% | 7.5% | 10.6% | 8.3% | 50.4% | 10.0% | 5.0% | 6.3% | 5.5% | 4.8% |
| Return on tangible equity | 9.7% | 8.4% | 11.3% | 9.1% | 45.8% | 11.0% | 5.4% | 6.8% | 6.3% | 5.7% |
| Growth | ||||||||||
| Revenue growth | β | β4.7% | 5.9% | 0.1% | 120.1% | β33.2% | β9.7% | β1.2% | β5.5% | 2.3% |
| Net income growth | β | β16.9% | 37.7% | β17.2% | 796.3% | β74.9% | β51.4% | 27.6% | β6.2% | β10.1% |
| EPS growth | β | β5.3% | 44.4% | β11.5% | 734.8% | β74.0% | β48.0% | 34.6% | 0.0% | β5.7% |
| FCF growth | β | β57.6% | β50.0% | 29.5% | 849.5% | β117.5% | β | 102.5% | β75.3% | β8.5% |
| Share count change | β | β10.9% | β6.9% | β5.7% | 6.1% | β3.4% | β5.3% | β7.2% | β5.2% | β6.1% |
| Financial health | ||||||||||
| Current ratio | 12.0x | 9.6x | 13.8x | 11.3x | 9.4x | 19.9x | 21.8x | 20.7x | 16.2x | 12.9x |
| Quick ratio | 7.6x | 6.0x | 8.6x | 6.4x | 6.6x | 10.5x | 11.7x | 12.8x | 8.9x | 7.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.6% | 2.8% | 1.3% | 2.8% | 1.1% | 3.7% | 0.8% | 1.3% | 6.6% | 1.1% |
| Stock comp / revenue | 0.4% | 0.7% | 0.9% | 1.0% | 0.4% | 0.5% | 0.2% | 0.3% | 0.8% | 0.9% |
| Payouts / FCF | 103.2% | 151.7% | 256.8% | 141.2% | 15.6% | β | 102.6% | 52.2% | 235.3% | 193.2% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 6.0 | 6.0 | 4.0 | 5.0 | 3.0 | 5.0 | 6.0 | 5.0 | 4.0 |
| Altman Z'' | 18.2 | 19.5 | 24.7 | 14.5 | 17.4 | 21.1 | 23.6 | 16.4 | 12.3 | 12.4 |
| Accruals ratio | β10.2% | β3.9% | 4.8% | β0.3% | 16.1% | 10.7% | β1.5% | β6.4% | β2.5% | 1.6% |
Source: SEC EDGAR XBRL filings (CIK 0000884269). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.